PR Public relations news

• FINEQIA SCHLIESST DRITTE TRANCHE DER PRIVATPLATZIERUNG FÜR INSGESAMT 4,76 MIO. CAD AB

  10-12-2022 23:40
  VANCOUVER, BC, 10. Dezember 2022 /PRNewswire/ -- Fineqia International Inc. (das „Unternehmen" oder „Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) gibt den Abschluss der dritten Tranche (die „dritte Tranche") seiner maklerunabhängigen Privatplatzierung (das „Angebot") bekannt. Das...
  
  Read more

• Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients with Myelofibrosis at American Society of Hematology 2022 Annual Meeting & Exposition

  10-12-2022 23:36
  CAMBRIDGE, Mass., Dec. 10, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today presented new data from the ongoing Phase 1/2 study evaluating TP-3654, an investigational selective oral PIM1 kinase inhibitor, in patients...
  
  Read more

• FINEQIA SLUIT TOT OP HEDEN DERDE TRANCHE VAN ONDERHANDSE PLAATSING VOOR TOTAAL CAD 4,76 MLN

  10-12-2022 23:33
  VANCOUVER, BC, 10 dec 2022 /PRNewswire/ -- Fineqia International Inc. (het "Bedrijf" of "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) kondigt de afsluiting aan van de derde tranche (de "Derde Tranche") van zijn niet-bemiddelde private plaatsing (het "Bod"). Het Bedrijf heeft 43.185....
  
  Read more

• FINEQIA CLÔTURE LA TROISIÈME TRANCHE DE SON PLACEMENT PRIVÉ POUR UN TOTAL DE 4,76 MILLIONS DE DOLLARS CANADIENS À CE JOUR

  10-12-2022 23:30
  VANCOUVER, Colombie-Britannique, 10 décembre 2022 /PRNewswire/ -- Fineqia International Inc. (la « Société » ou « Fineqia ») (CSE : FNQ) (OTC : FNQQF) (Francfort : FNQA) annonce la clôture de la troisième tranche (la « Troisième tranche ») de son placement privé sans courtier (le «...
  
  Read more

• Advertisement

• Servier Presents Patient Follow Up Data from the Phase 3 AGILE Study at ASH 2022

  10-12-2022 23:27
  
  New data details molecular characterization of clinical response in patients with IDH1-mutated, newly-diagnosed acute myeloid leukemia (AML) treated with TIBSOVO® (ivosidenib tablets) in combination with azacitidine in the global Phase 3 AGILE study BOSTON, Dec. 10, 2022 /PRNewswire/ --...
  
  Read more

• Syndax Announces Positive Updated Data from Phase 1 Portion of AUGMENT-101 Trial of Revumenib in Patients with Acute Leukemias During Oral Presentations at 64th ASH Annual Meeting

  10-12-2022 23:00
  - 30% CR/CRh rate in efficacy evaluable population; 27% CR/CRh rate observed in both mNPM1 and KMT2Ar (MLLr) R/R acute leukemia patients treated at RP2D - - 9 of 12 patients who underwent stem cell transplant after achieving a response with revumenib remained in remission, with four...
  
  Read more

• AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting for Investigational Navitoclax in Combination With Ruxolitinib for JAK Inhibitor-Naïve Myelofibrosis Patients

  10-12-2022 21:00
  Exploratory analysis from Cohort 3 of the Phase 2 REFINE study presented in an oral session at ASH NORTH CHICAGO, Ill., Dec. 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new data from Cohort 3 of its Phase 2 REFINE study of investigational navitoclax in combination with...
  
  Read more

• CGTN : Enquête : 85 % des personnes interrogées louent le concept chinois de destin partagé

  10-12-2022 19:52
  BEIJING, 10 décembre 2022 /PRNewswire/ -- Pas moins de 85 % des personnes interrogées à une enquête mondiale ont salué le concept de « communauté de destin pour l'humanité », tandis que 94,2 % d'entre elles ont apprécié les valeurs proposées par la Chine pour toute l'humanité : « paix,...
  
  Read more

• Advertisement

• Janssen Presents First Data from MajesTEC-2 Trial of TECVAYLI™ (teclistamab-cqyv) in Combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and Lenalidomide in Relapsed or Refractory Multiple Myeloma

  10-12-2022 19:00
  
  Initial Phase 1b study results show clinical activity with immune-based triplet therapy regimen NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from a cohort of the Phase 1b MajesTEC-2 study of TECVAYLI™...
  
  Read more

• Research Highlights Cutting-Edge New Treatments for Blood Disorders

  10-12-2022 18:56
  
  Scientists present on novel therapeutic approaches and new treatment paradigms NEW ORLEANS, La., Dec. 10, 2022 /PRNewswire/ -- New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches for several...
  
  Read more

• New Studies Challenge the Dogma of Blood Cancer Care

  10-12-2022 17:48
  
  Research calls into question longstanding assumptions and charts a path for gentler therapies NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ --Research findings being presented during the 64th American Society of Hematology (ASH) Annual Meeting and Exposition challenge standard practices in...
  
  Read more

• ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Torrid Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action - CURV

  10-12-2022 17:45
  
  NEW YORK, Dec. 10, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Torrid Holdings (NYSE: CURV) pursuant and/or traceable to the Company's initial public offering conducted in July 2021 (the "IPO"), of the important...
  
  Read more

• Janssen Presents New Data for Talquetamab, a First-in-Class GPRC5DxCD3 Bispecific Antibody, Suggesting Durable Responses in Patients with Heavily Pretreated Multiple Myeloma

  10-12-2022 17:43
  
  Results from the pivotal MonumenTAL-1 study, including first results from the Phase 2 portion, featured at the 2022 ASH Annual Meeting NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the Phase 1/2...
  
  Read more

• Conozca la solución Whale Photo de ZEASN, socio de AWS

  10-12-2022 17:34
  
  PEKÍN, 10 de diciembre de 2022 /PRNewswire/ -- ZEASN, el principal operador de ecosistemas domésticos inteligentes del mundo, recomienda hoy Whale Photo, una solución inteligente integral para marcos de fotos digitales, que incluye software de sistema, servicio en la nube y aplicación...
  
  Read more

• Lernen Sie die Whale-Photo-Lösung von ZEASN - einem AWS-Partner - kennenr

  10-12-2022 17:33
  
  PEKING, 10. Dezember 2022 /PRNewswire/ -- ZEASN, der weltweit führende Anbieter von Smart-Home-Ökosystemen, empfiehlt heute Whale Photo, eine intelligente Lösung für digitale Bilderrahmen aus einer Hand, die Systemsoftware, Cloud-Service und mobile App umfasst und darauf abzielt, ein...
  
  Read more

• Découvrez la solution Whale Photo de ZEASN - un partenaire AWS

  10-12-2022 17:23
  
  PÉKIN, 10 décembre 2022 /PRNewswire/ -- ZEASN, le plus grand exploitant d'écosystème d'habitat intelligent au monde, recommande aujourd'hui Whale Photo, une solution intelligente tout-en-un de cadres photos numériques qui comprend un logiciel système, un service cloud et une application...
  
  Read more

• Conociendo la solución Whale Photo deZEASN: un socio de AWS

  10-12-2022 17:18
  
  Pekín, 10 de diciembre de 2022 /PRNewswire/ -- ZEASN, el operador líder a nivel mundial en ecosistemas de hogares inteligentes, recomienda hoy Whale Photo, una solución inteligente integral para marcos fotográficos digitales, que incluye software del sistema, servicio en la nube y...
  
  Read more

• AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Adds to Robust IMBRUVICA® (ibrutinib) Science

  10-12-2022 17:15
  Updated data presented at ASH include CAPTIVATE and GLOW studies and real-world evidence abstracts NORTH CHICAGO, Ill., Dec. 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new and updated data across clinical and real-world studies in chronic lymphocytic leukemia (CLL)....
  
  Read more

• New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA® (ibrutinib) Plus Venetoclax Demonstrate Robust Efficacy and Sustained Response in Older, Unfit Patients with Previously Untreated Chronic Lymphocytic Leukemia

  10-12-2022 16:54
  With nearly four years of study follow-up, all-oral, fixed duration IMBRUVICA® + venetoclax reduced the risk of progression or death by 79 percent and demonstrated overall survival (OS) advantage versus chemoimmunotherapy NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ -- The Janssen...
  
  Read more

• Im Folgenden eine Testveröffentlichung - ÄÖÜäößü

  10-12-2022 16:04
  Das ist eine Testveröffentlichung - ÄÖÜäößü NEW YORK, 10. Dezember 2022 /PRNewswire/ -- Das ist eine Testveröffentlichung. Das ist eine Testveröffentlichung. Das ist eine Testveröffentlichung. Das ist eine Testveröffentlichung. Das ist eine Testveröffentlichung. Das ist eine...
  
  Read more

• Le texte suivant est une version test - ÀÂÆÇÉÈÊËÎÏÔŒÙÛÜŸàâæçéèêëîïôœùûüÿ

  10-12-2022 16:01
  Ceci est une version test - ÀÂÆÇÉÈÊËÎÏÔŒÙÛÜŸàâæçéèêëîïôœùûüÿ NEW YORK, 10 décembre 2022 /PRNewswire/ -- Ceci est une version test. Ceci est une version test. Ceci est une version test. Ceci est une version test. Ceci est une version test. Ceci est une version test. Ceci est une version...
  
  Read more

• CSL's Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B at 24-Months Post-Treatment

  10-12-2022 16:00
  
  Long-term data from the pivotal HOPE-B study show a one-time infusion of HEMGENIX generated elevated and sustained mean factor IX levels and reduced the rate of annual bleeding 24-month results reinforced safety of treatment, with no serious treatment-related adverse effects related to...
  
  Read more

• Research Exposes Inequities in Health Care Access and Delivery for Blood Disorders

  10-12-2022 15:49
  
  Scientists identify barriers and suggest opportunities to close gaps NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ -- Four studies presented during the 64th American Society of Hematology (ASH) Annual Meeting and Exposition uncover significant disparities in medical care and health outcomes...
  
  Read more

• CGTN: China-Arab summit carries forward traditional friendship, fosters closer community with shared future

  10-12-2022 15:33
  BEIJING, Dec. 10, 2022 /PRNewswire/ -- The first China-Arab States Summit was held successfully on Friday in the presence of Chinese President Xi Jinping and more than 10 Arab leaders. The event, which was an opportunity to bring China-Arab relations to new heights, to elaborate on the...
  
  Read more

• CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against The Gap, Inc.

  10-12-2022 15:02
  
  RADNOR, Pa., Dec. 10, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against The Gap, Inc. ("Gap") (NYSE: GPS). The action charges Gap with violations of the federal securities...
  
  Read more

• CGTN:China to step up cooperation with Arab states under BRI, GDI, GSI

  10-12-2022 14:47
  BEIJING, Dec. 10, 2022 /PRNewswire/ -- Chinese President Xi Jinping has said China will continue to enhance cooperation with Arab states under the Belt and Road Initiative (BRI), the Global Development Initiative (GDI) and the Global Security Initiative (GSI). He made the remarks during...
  
  Read more

• Female contraceptive market size to grow by USD 5,142.22 million: Personal products industry is the parent market - Technavio

  10-12-2022 13:45
  
  NEW YORK, Dec. 10, 2022 /PRNewswire/ -- The global female contraceptive market has been categorized as a part of the global personal products market. The parent market, the global personal products market, covers products and companies engaged in the research and development (R&D) and...
  
  Read more

• ROYAL CARIBBEAN OFFICIALLY NAMES THE WORLD'S NEWEST WONDER, WONDER OF THE SEAS

  10-12-2022 13:08
  
  The Celebration in Port Canaveral, Florida, Honors a Mother from Pennsylvania as the Godmother of the New Ship MIAMI, Dec. 10, 2022 /PRNewswire/ -- A celebration fit for the world's newest wonder lit up Port Canaveral, Florida, last night when Royal Caribbean International officially...
  
  Read more

• ROSEN, A LEADING LAW FIRM, Encourages Provident Bancorp, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - PVBC

  10-12-2022 12:44
  
  NEW YORK, Dec. 10, 2022 /PRNewswire/ -- WHY: New York, N.Y., December 10, 2022. Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Provident Bancorp, Inc. (NASDAQ: PVBC) resulting from allegations that...
  
  Read more

• TraceyBryantStuckey.com Congratulates all of the National Board Certified Teachers on Score Release Day

  10-12-2022 10:32
  COLUMBIA, S.C., Dec. 10, 2022 /PRNewswire/ -- December 10th is a big day in the K-12 education world with the National Board for Professional Teaching Standards (NBPTS) releasing Initial Certification and Renewal Maintenance of Certification (MOC) score reports. "Congratulations on this...
  
  Read more

• PLDT, Smart recognized for whole-of-nation approach to child protection, reinforcing sustainability

  10-12-2022 06:06
  MANILA, Philippines, Dec. 10, 2022 /PRNewswire/ --The recent Global Child Forum brought to the fore, best practices of private companies worldwide, including PLDT and Smart's whole-of-nation approach to safeguard children. Held at the Royal Palace in the presence of the King and Queen of...
  
  Read more

• STAR POWER & PitPat: A Treadmill that Lets You Compete at Home

  10-12-2022 06:00
  HOUSTON, Dec. 10, 2022 /PRNewswire/ -- The unique innovation of the STAR POWER treadmill, which brings offline races online, is that you can participate in races even when you run at home. By accessing the application developed by STAR POWER with the activity tracker, users can access the...
  
  Read more

• CAYK Marketing Inc. ranks as global leaders in Advertising & Marketing vertical for 2022

  10-12-2022 05:40
  CALGARY, AB, Dec. 9, 2022 /PRNewswire/ - CAYK Marketing Inc is a Digital Marketing Agency in Calgary that helps drive the success of the organizations they work with by utilizing data, the latest technologies and careful strategic planning to drive businesses forward. CAYK Recognized by...
  
  Read more

• CGTN: Infrastructure, vaccines and space: China-Arab sci-tech cooperation

  10-12-2022 05:30
  
  BEIJING, Dec. 10, 2022 /PRNewswire/ -- Under the Belt and Road Initiative (BRI), China-Arab cooperation in the fields of infrastructure, space and health has been continuously developed in a sustainable manner. China has vowed to accelerate the development of the China-Arab...
  
  Read more

• CGTN: China-GCC relations elevated to new level as first China-GCC Summit held in Riyadh

  10-12-2022 05:18
  BEIJING, Dec. 10, 2022 /PRNewswire/ -- As the China-Gulf Cooperation Council (GCC) Summit brought the leaders of China and the GCC countries together for the first time in Riyadh, Saudi Arabia, the traditional friendship between the two sides has been carried forward and the strategicness...
  
  Read more

• CGTN: Deepening China-Arab energy cooperation born of win-win scenarios

  10-12-2022 05:05
  
  BEIJING, Dec. 10, 2022 /PRNewswire/ -- The Arab countries located at the junction of Asia, Africa and Europe are universally renowned for their unique geographic location and abundant energy reserves. Energy cooperation, one of the main components of the China-Arab partnership, has...
  
  Read more

• Nederlander Theatrical Corp. Provides Notice of Data Security Event

  10-12-2022 05:00
  It is important to note that individuals who purchased tickets for performances online or at a box office location were not impacted by this event. NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Nederlander became aware of suspicious activity in its environment. We immediately took steps to...
  
  Read more

• NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO

  10-12-2022 04:50
  
  NEW ORLEANS, Dec. 9, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against...
  
  Read more

• GENERAC HOLDINGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Generac Holdings Inc. - GNRC

  10-12-2022 04:50
  
  NEW ORLEANS, Dec. 9, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 30, 2023 to file lead plaintiff applications in a securities class action lawsuit against...
  
  Read more

• FIGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against FIGS, Inc. - FIGS

  10-12-2022 04:50
  
  NEW ORLEANS, Dec. 9, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 3, 2023 to file lead plaintiff applications in securities class action lawsuits against FIGS,...
  
  Read more

• F45 TRAINING HOLDINGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against F45 Training Holdings, Inc. - FXLV

  10-12-2022 04:50
  
  NEW ORLEANS, Dec. 9, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against F45...
  
  Read more

• FXLV INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages F45 Training Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FXLV

  10-12-2022 04:12
  
  NEW YORK, Dec. 9, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of F45 Training Holdings Inc. (NYSE: FXLV) pursuant and/or traceable to the registration statement and...
  
  Read more

• Presentan el programa Connected California para cerrar la brecha digital

  10-12-2022 03:20
  
  Programa apoyado por la Biblioteca del Estado de California, Southern California Library Cooperative y bibliotecas locales PASADENA, California, 9 de diciembre de 2022 /PRNewswire-HISPANIC PR WIRE/ -- ¡Conéctate, California! La Biblioteca del Estado de California y Southern California...
  
  Read more

• El proyecto Boulevard World Metasight de Unilumin en Arabia Saudí recibe grandes elogios

  10-12-2022 03:12
  
  -Los elementos chinos brillan en Arabia Saudí y el proyecto Boulevard World Metasight de Unilumin recibe grandes elogios SHENZHEN, China, 10 de diciembre de 2022 /PRNewswire/ -- En Riad, la capital de Arabia Saudí, los elementos chinos llevan mucho tiempo penetrando en la vida de la gente...
  
  Read more

• ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Silvergate Capital Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SI

  10-12-2022 03:10
  
  NEW YORK, Dec. 9, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Silvergate Capital Corporation (NYSE: SI) between November 9, 2021 and November 17, 2022, both dates...
  
  Read more

• Chinesische Elemente glänzen in Saudi-Arabien, und der Boulevard „World Metasight"-Projekt von Unilumin wurde in den höchsten Tönen gelobt

  10-12-2022 03:04
  
  SHENZHEN, China, 10. Dezember 2022 /PRNewswire/-- In der saudi-arabischen Hauptstadt Riad sind chinesische Elemente seit Langem Bestandteil des Lebens der Menschen und der nationalen Entwicklung. Unter den chinesischen Elementen wurde das am 21. November in Riad gestartete Boulevard World...
  
  Read more

• Los elementos chinos brillan en Arabia Saudí, y el proyecto Metavisión Mundial Boulevard de Unilumin recibió numerosos elogios.

  10-12-2022 03:01
  
  SHENZHEN, China, 9 de diciembre de 2022 /PRNewswire/ -- En Riad, la capital de Arabia Saudí, los elementos chinos forman parte desde hace mucho tiempo de la vida de las personas y del desarrollo nacional. Entre todos los elementos chinos, el Proyecto Viajes Culturales Mundiales Boulevard,...
  
  Read more

• Shenzhen organise l'édition 2022 de la Conférence sur la promotion des investissements mondiaux afin d'attirer les investisseurs internationaux

  10-12-2022 02:47
  SHENZHEN, Chine, 10 décembre 2022 /PRNewswire/ -- Shenzhen accueille des investisseurs exceptionnels du monde entier. L'édition 2022 de la Conférence sur la promotion des investissements mondiaux de Shenzhen se tiendra à Shenzhen, en Chine, le 9 décembre. Un certain nombre de grands...
  
  Read more

• Shenzhen veranstaltet die Global Investment Promotion Conference 2022, um internationale Investoren anzuziehen.

  10-12-2022 02:42
  SHENZHEN, China, 10. Dezember 2022 /PRNewswire/ -- Shenzhen begrüßt herausragende Investoren aus allen Teilen der Welt. Die 2022 Shenzhen Global Investment Promotion Conference 2022 findet am 9. Dezember in Shenzhen, China, statt. Es werden Verträge bezüglich Großprojekten in den...
  
  Read more

• Darling Ingredients allekirjoittaa sitoumuskirjeen Science Based Targets initiative (SBTi) -aloitteeseen ja jatkaa vuoden 2050 nollapäästötavoitteen edistämistä

  10-12-2022 02:26
  
  IRVING, Teksas, 10. joulukuuta 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR), maailman johtava ruokajätettä kestäviksi tuotteiksi ja uusiutuvaksi energiaksi muuttava yritys on allekirjoittanut sitoumuskirjeen Science Based Targets initiative (SBTi) -aloitteeseen ja Business...
  
  Read more

Follow @PR_UKnws on Twitter!